SONN - Sonnet BioTherapeutics Holdings, Inc.
1.26
-1.840 -146.032%
Share volume: 10,456,154
Last Updated: 12-02-2025
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$3.10
-1.84
-0.59%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2024 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-14-2024 | 08-14-2024 | 02-13-2025 | 02-13-2025 | 05-13-2025 | 08-13-2025 | 12-16-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | |||||
| Operating expenses | 3.869 M | 3.529 M | 3.173 M | 0.000 | 4.229 M | 3.806 M | 0.000 | |
| Selling general and admin | 1.701 M | 1.802 M | 1.974 M | 0.000 | 2.345 M | 1.381 M | 0.000 | |
| Research and development | 2.167 M | 1.727 M | 1.199 M | 0.000 | 1.885 M | 2.426 M | 0.000 | |
| Total expenses | 3.869 M | 3.529 M | 3.173 M | 0.000 | 4.229 M | 3.806 M | 0.000 | |
| -8.79% | -10.07% | -100.00% | -10.00% | -100.00% | ||||
| Operating income | -3.869 M | -3.529 M | -3.173 M | 0.000 | -4.229 M | -3.806 M | 0.000 | |
| Ebit | 365.425 K | -3.506 M | -3.129 M | -3.002 M | -3.491 M | -3.776 M | 0.000 | |
| Pretax income | 365.425 K | -3.506 M | -3.129 M | 0.000 | -3.491 M | -3.776 M | 0.000 | |
| -1,059.31% | -10.75% | -100.00% | 8.15% | -100.00% | ||||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 365.425 K | -3.506 M | -3.129 M | 0.000 | -3.491 M | -3.776 M | 0.000 | |
| -1,059.31% | 10.75% | 100.00% | -8.15% | 100.00% |